These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
150 results:

  • 1. Sulfated Polyhydroxysteroid Glycosides from the Sea of Okhotsk Starfish
    Kicha AA; Tolkanov DK; Malyarenko TV; Malyarenko OS; Kuzmich AS; Kalinovsky AI; Popov RS; Stonik VA; Ivanchina NV; Dmitrenok PS
    Mar Drugs; 2024 Jun; 22(7):. PubMed ID: 39057403
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression.
    Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
    Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
    Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
    Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. 1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation.
    Hwang SJ; Cho SH; Bang HJ; Hong JH; Kim KH; Lee HJ
    Biochem Pharmacol; 2024 Feb; 220():115972. PubMed ID: 38072164
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [
    Wollenberg L; Hahn E; Williams J; Litwiler K
    Pharmacol Res Perspect; 2023 Oct; 11(5):e01140. PubMed ID: 37775918
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in colorectal cancer.
    Heuvelings DJI; Wintjens AGWE; Moonen L; Engelen SME; de Hingh IHJT; Valkenburg-van Iersel LB; den Dulk M; Beckervordersandforth J; Thijssen SGM; Leunissen DJG; Stassen LPS; Keszthelyi D; Mujagic Z; Speel EM; Bouvy ND
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629011
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
    Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. raf1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status.
    Dorard C; Madry C; Buhard O; Toifl S; Didusch S; Ratovomanana T; Letourneur Q; Dolznig H; Garnett MJ; Duval A; Baccarini M
    Oncogene; 2023 May; 42(20):1649-1660. PubMed ID: 37020037
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of craf and MEK1/2.
    Wang P; Jia X; Lu B; Huang H; Liu J; Liu X; Wu Q; Hu Y; Li P; Wei H; Liu T; Zhao D; Zhang L; Tian X; Jiang Y; Qiao Y; Nie W; Ma X; Bai R; Peng C; Dong Z; Liu K
    Signal Transduct Target Ther; 2023 Mar; 8(1):96. PubMed ID: 36872366
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Melatonin-Assisted Cisplatin Suppresses Urinary Bladder cancer Cell Proliferation and Growth through Inhibiting PrP
    Yang CC; Chuang FC; Chang CL; Huang CR; Chen HH; Yip HK; Chen YT
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834767
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. α4-α5 Helices on Surface of KRAS Can Accommodate Small Compounds That Increase KRAS Signaling While Inducing CRC Cell Death.
    Abuasaker B; Garrido E; Vilaplana M; Gómez-Zepeda JD; Brun S; Garcia-Cajide M; Mauvezin C; Jaumot M; Pujol MD; Rubio-Martínez J; Agell N
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614192
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-raf and MAPK signaling cascade.
    Qian Y; Zhou L; Luk STY; Xu J; Li W; Gou H; Chen H; Kang W; Yu J; Wong CC
    Oncogene; 2023 Feb; 42(8):601-612. PubMed ID: 36564468
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Anticancer Properties of Selenium-Enriched Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), in Colon cancer In Vitro.
    Fekry T; Salem MF; Abd-Elaziz AA; Muawia S; Naguib YM; Khalil H
    Int J Med Mushrooms; 2022; 24(11):1-20. PubMed ID: 36374945
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The tumour/normal tissue ratio of Keap1 protein is a predictor for lymphovascular invasion in colorectal cancer: a correlation study between the Nrf2 and KRas pathways.
    Chang LC; Fan CW; Tseng WK; Chen JR; Hua CC
    Biomarkers; 2022 Nov; 27(7):701-707. PubMed ID: 35830714
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Circ_CDR1as: A circular RNA with roles in the carcinogenesis.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Sarfaraz S; Taheri M; Ayatollahi SA
    Pathol Res Pract; 2022 Aug; 236():153968. PubMed ID: 35667198
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Pan X; Hou X; Zhang F; Tang P; Wan W; Su Z; Yang Y; Wei W; Du Z; Deng J; Hao E
    Pharm Biol; 2022 Dec; 60(1):915-930. PubMed ID: 35587342
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Anticancer drug resistance: An update and perspective.
    Nussinov R; Tsai CJ; Jang H
    Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal cancer proliferation.
    Ma W; Chen Y; Xiong W; Li W; Xu Z; Wang Y; Wei Z; Mou T; Wu Z; Cheng M; Zou Y; Zhu Y; Zhou W; Liu F; Geng Y
    J Exp Clin Cancer Res; 2021 Nov; 40(1):359. PubMed ID: 34781982
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma.
    Al Shahrani M; Abohassan M; Y Alshahrani M; Hakami AR; Rajagopalan P
    J Comput Aided Mol Des; 2021 Dec; 35(12):1165-1176. PubMed ID: 34727304
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.